Science

Apr 17, 2025, 09:27

Myeloma Paper of the Day, April 17th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Patients post-ASCT on Len maint with sustained MRD negativity for >6 mos have superior 3-year PFS vs. those without sustained MRD measured by NGF (100% vs. 67.6%; HR 0.06; P<0.007) and NGS (90.5% vs. 72.2%; HR 0.23; P=0.048).”

“Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study”

Authors: Takeshi Yoroidaka, Hiroyuki Takamatsu, Ryota Urushihara, Mitsuhiro Itagaki, Satoshi Yoshihara, Tadao Ishida, Kenshi Suzuki, Hirokazu Murakami, Brian Durie, Kazuyuki Shimizu et al.

More posts featuring Robert Orlowski.

Brian Durie cancer EuroFlow Hirokazu Murakami Hiroyuki Takamatsu Kazuyuki Shimizu Kenshi Suzuki Mitsuhiro Itagaki multiple myeloma Myeloma Paper of the Day NGF NGS OncoDaily Oncology Robert Orlowski Ryota Urushihara Satoshi Yoshihara Tadao Ishida Takeshi Yoroidaka

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute